|Videos|June 21, 2017

How Might Legionella Get into A Car's Windshield Washer Fluid?

Otto Schwake, PhD, postulates how Legionella might get into automobile windshield washer fluid and if there is any way to prevent it.

Otto Schwake, PhD, Department of Civil and Environmental Engineering at Virginia Tech, postulates how Legionella might get into automobile windshield washer fluid and if there is any way to prevent it.

Interview Transcript (slightly modified for readability).

“These are ubiquitous organisms; they’re found all over the place. Their main habitats in nature are fresh water, rivers, and lakes, but anywhere from nearing boiling geyser runoff, to permanently below zero Antarctic lakes, [are places] we can find these microbes. So, it shouldn’t be a surprise that they get into our tap water a lot, and that’s really where we think they are getting into washer fluid. [This can happen] by car owners just putting straight water into their cars, or deluding a concentrated washer solution, or the washer manufacturers themselves using nonsterile water — which I don’t know, but I would predict they’re not going to be sterilizing their water too much, but they’re maybe treating it somehow. We think that it’s really the tap water that’s getting contaminated with Legionella, originally from lakes or rivers, wherever the tap water source is, and eventually getting into the cars.

Now, is there a way to prevent it? We don’t know; it’s really hard to say. Preventing it [from] getting in the cars, [such as] boiling your tap water, boiling your washer fluid, kind of defeats the purpose. At this stage in the research where we’re really just learning where they are in cars, it’s kind of premature to say if there’s a way to prevent them from getting in there in the first place. [If] you talk to different people about this project, you [can discuss] ideas about ways to lower the numbers once they’re in there, but again, until we get a better grasp on [where] they’re in cars, we can’t really say how we can stop them from getting in cars.”


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.